Experimental drug improves sleep in older patients, Wake Forest Baptist study shows

May 06, 2004

WINSTON-SALEM, N.C. - Older people with insomnia slept better and longer after taking an experimental sleep medication, according to research at Wake Forest University Baptist Medical Center.

W. Vaughn McCall, M.D., a sleep expert, presented his findings today (May 6) at the annual meeting of the American Psychiatric Association in New York City. The study showed the drug, called eszopiclone, significantly reduced both the amount of time it took to fall asleep and the tendency to wake up repeatedly once sleep had begun. It also increased total sleep time.

McCall, who also is professor and chairman of the Department of Psychiatry and Behavioral Medicine at Wake Forest Baptist, said the patients were monitored in the medical center's sleep laboratory, so sleep could be documented by its equipment.

The 264 insomnia patients in the study, all between 65 and 85 years old, were randomly assigned to either take eszopiclone or an inactive placebo, and neither patient nor the staff monitoring them knew which they were taking. Each patient completed sleep diaries every night for two weeks.

When the code was broken to determine which patients were on placebo and who got the actual drug, patients treated with eszopiclone showed improvement in all measures of insomnia including falling asleep, staying asleep and total sleep time, as well as a reduction in frequency and duration of napping, he said.

Though 40 million Americans suffer from insomnia, McCall said the study focused on patients 65 and older because insomnia tends to be more common in older people.

"The elderly are more easily awakened by noise, pain or light and tend to have difficulty sleeping for extended periods and achieving deep, restful sleep states," McCall said. "As a result, elderly adults often get less sleep than they need, leading to increased napping or diminished next-day functioning, which can impact their quality of life

McCall said the study also evaluated patients on whether their quality of life improved, using standard quality of life tests. The results showed significant improvement on eszopiclone. "Since improving patients' quality of life is the goal of treatment, this is an interesting finding that merits further study," he said.

Eszopiclone is made by Sepracor Inc., a pharmaceutical company, which paid for the study.
Media Contacts: Robert Conn (rconn@wfubmc.edu), Shannon Koontz, shkoontz@wfubmc.edu, or Karen Richardson, krchrdsn@wfubmc.edu, at 336-716-4587.

About Wake Forest University Baptist Medical Center: Wake Forest Baptist is an academic health system comprised of North Carolina Baptist Hospital and Wake Forest University School of Medicine. It is licensed to operate 1,282 acute care, psychiatric, rehabilitation and long-term care beds and is consistently ranked as one of "America's Best Hospitals" by U.S. News & World Report.

Wake Forest Baptist Medical Center

Related Insomnia Articles from Brightsurf:

Insomnia treatment offers relief
Insomnia causing sleepless nights, daytime fatigue and poor health outcomes is a cycle worth busting, experts say, with depression, anxiety and stress a common co-occurrence.

Reduction in insomnia symptoms associated with non-invasive neurotechnology
For people with chronic insomnia, a good night's sleep is elusive.

The neurons that connect stress, insomnia, and the immune system
Researchers have pinpointed the circuit in the brain that is responsible for sleepless nights in times of stress--and it turns out that circuit does more than make you toss and turn.

Refined carbs may trigger insomnia, finds study
Women who consumed a diet high in added sugars and refined carbohydrates had a greater risk of developing insomnia, a new study by researchers at Columbia University has found.

Disturbed childhood can lead to adult insomnia
Parents should help their children with better sleep patterns, along with any problem behavioural issues, because this can lead to severe insomnia in middle age, a groundbreaking new study shows.

Study compares different strategies for treating insomnia
New research published in Worldviews on Evidence-Based Nursing indicates that for treating insomnia, stimulus control therapy (which reassociates the bed with sleepiness instead of arousal) and sleep restriction therapy are effective, and it is best to use them individually rather than together.

Brain cells involved in insomnia identified
An international team of researchers has identified, for the first time, the cell types, areas and biological processes in the brain that mediate the genetic risk of insomnia.

Mice sleeping fitfully provide clues to insomnia
Researchers at Washington University School of Medicine in St. Louis -- working with mice with sleep problems similar to those experienced by people with the genetic disease neurofibromatosis type 1 (NF1) -- believe the animals will help shed light on insomnia linked to NF1 or other factors.

Insomnia has many faces
Researchers at the Netherlands Institute for Neuroscience revealed that there are five types of insomnia.

Light pollution may cause insomnia in older adults
A new study is the first population-based investigation to report a significant association between artificial, outdoor light exposure at night and insomnia, as indicated by older adults' use of hypnotic drugs.

Read More: Insomnia News and Insomnia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.